Historical shareholding details of Strategic Advisers U.S. Total Stock holdings in Fate Therapeutics Inc (FATE)

Monthly changes of Strategic Advisers U.S. Total Stock shareholding in Fate Therapeutics Inc over the previous months

Month Name Total no. shares held Percent Holding
Jan 31, 2025 Strategic Advisers U.S. Total Stock 9,371 0.01%
Dec 31, 2024 Strategic Advisers U.S. Total Stock 10,571 0.01%
Nov 30, 2024 Strategic Advisers U.S. Total Stock 10,571 0.01%
Oct 31, 2024 Strategic Advisers U.S. Total Stock 12,671 0.01%
Sep 30, 2024 Strategic Advisers U.S. Total Stock 18,593 0.02%
Jul 31, 2024 Strategic Advisers U.S. Total Stock 18,600 0.02%
Jun 30, 2024 Strategic Advisers Large Cap 30,300 0.03%
May 31, 2024 Strategic Advisers Large Cap 38,600 0.03%
Apr 30, 2024 Strategic Advisers Large Cap 27,400 0.02%
Mar 31, 2024 Strategic Advisers Large Cap 23,900 0.02%
Feb 29, 2024 Strategic Advisers Large Cap 12,100 0.01%
Jan 31, 2024 Strategic Advisers Large Cap 9,200 0.01%
Dec 31, 2023 Strategic Advisers Large Cap 9,100 0.01%
Oct 31, 2023 Strategic Advisers® Large Cap 3,800 0.00%
Sep 30, 2023 Strategic Advisers® Large Cap 3,800 0.00%
Jul 31, 2023 Strategic Advisers® Large Cap 3,800 0.00%
Jun 30, 2023 Strategic Advisers® Large Cap 3,800 0.00%
Apr 30, 2023 Strategic Advisers® Large Cap 1,100 0.00%

View all ownership details of Fate Therapeutics Inc